205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.47%
Revenue growth above 1.5x QCOM's 1.94%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.31%
Positive gross profit growth while QCOM is negative. John Neff would see a clear operational edge over the competitor.
37.52%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
-6.84%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-4.70%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-5.08%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-3.45%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.63%
Share reduction while QCOM is at 0.29%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.54%
Reduced diluted shares while QCOM is at 0.11%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.31%
Dividend growth under 50% of QCOM's 39.73%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
70.77%
Positive OCF growth while QCOM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
77.99%
Positive FCF growth while QCOM is negative. John Neff would see a strong competitive edge in net cash generation.
100.90%
10Y revenue/share CAGR under 50% of QCOM's 520.14%. Michael Burry would suspect a lasting competitive disadvantage.
13.95%
5Y revenue/share CAGR under 50% of QCOM's 112.81%. Michael Burry would suspect a significant competitive gap or product weakness.
-6.30%
Negative 3Y CAGR while QCOM stands at 117.62%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
254.02%
10Y OCF/share CAGR at 50-75% of QCOM's 450.98%. Martin Whitman might fear a structural deficiency in operational efficiency.
30.17%
Below 50% of QCOM's 164.26%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-5.66%
Negative 3Y OCF/share CAGR while QCOM stands at 106.01%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
120.73%
Below 50% of QCOM's 654.58%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
32.93%
Below 50% of QCOM's 98.88%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-20.90%
Negative 3Y CAGR while QCOM is 94.31%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
51.69%
Below 50% of QCOM's 377.43%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
30.26%
Below 50% of QCOM's 110.27%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.84%
Below 50% of QCOM's 78.24%. Michael Burry suspects a serious short-term disadvantage in building book value.
1205.79%
Dividend/share CAGR of 1205.79% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
179.73%
5Y dividend/share CAGR above 1.5x QCOM's 117.88%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
132.68%
3Y dividend/share CAGR above 1.5x QCOM's 84.38%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
2.21%
AR growth well above QCOM's 3.18%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.35%
Inventory shrinking or stable vs. QCOM's 16.37%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.79%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.48%
Positive BV/share change while QCOM is negative. John Neff sees a clear edge over a competitor losing equity.
-0.08%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-5.40%
Our R&D shrinks while QCOM invests at 6.92%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.27%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.